HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick A Zweidler-Mckay Selected Research

Central Nervous System Diseases (CNS Diseases)

10/2020Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick A Zweidler-Mckay Research Topics

Disease

3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2020 - 10/2018
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2020 - 10/2018
1Central Nervous System Diseases (CNS Diseases)
10/2020

Drug/Important Bio-Agent (IBA)

2Methotrexate (Mexate)FDA LinkGeneric
10/2020 - 10/2018
2pegaspargase (Oncaspar)FDA Link
10/2020 - 10/2018
2Leucovorin (Folinic Acid)FDA Link
10/2020 - 10/2018
1nelarabine (506U78)FDA Link
10/2020
1ElementsIBA
12/2019
1DNA (Deoxyribonucleic Acid)IBA
12/2019
1methylervineIBA
10/2018

Therapy/Procedure

2Therapeutics
10/2020 - 10/2018
1Cranial Irradiation
10/2018